Free Trial

Genocea Biosciences (GNCAQ) Short Interest Ratio & Short Volume

Genocea Biosciences logo

Genocea Biosciences Short Interest Data

Genocea Biosciences (GNCAQ) has a short interest of 195,100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1,951.0, indicating that it would take 1,951.0 days of the average trading volume of 1,863 shares to cover all short positions.

Current Short Interest
195,100 shares
Previous Short Interest
195,100 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$0.00
Short Interest Ratio
1,951.0 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
58,730,000 shares
Percentage of Shares Shorted
0.33%
Today's Trading Volume
0 shares
Average Trading Volume
1,863 shares
Today's Volume Vs. Average
0%
Short Selling Genocea Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genocea Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNCAQ Short Interest Over Time

GNCAQ Days to Cover Over Time

GNCAQ Percentage of Float Shorted Over Time

Genocea Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2025195,100 shares $0.00 No ChangeN/A1951 $0.00
4/30/2025195,100 shares $0.00 No ChangeN/A0 $0.00
4/15/2025195,100 shares $0.00 No ChangeN/A1951 $0.00
3/14/2025195,100 shares $0.00 No ChangeN/A975.5 $0.00
2/28/2025195,100 shares $0.00 No ChangeN/A975.5 $0.00
2/14/2025195,100 shares $0.00 No ChangeN/A975.5 $0.00
1/31/2025195,100 shares $0.00 No ChangeN/A216.8 $0.00
1/15/2025195,100 shares $0.00 No ChangeN/A162.6 $0.00

GNCAQ Short Interest - Frequently Asked Questions

What is Genocea Biosciences' current short interest?

Short interest is the volume of Genocea Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 195,100 shares of GNCAQ short. Learn More on Genocea Biosciences' current short interest.

What is a good short interest ratio for Genocea Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNCAQ shares currently have a short interest ratio of 1,951.0. Learn More on Genocea Biosciences's short interest ratio.

How does Genocea Biosciences' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genocea Biosciences: Aridis Pharmaceuticals, Inc. (0.00%), Scopus BioPharma Inc. (0.02%), eFFECTOR Therapeutics, Inc. (0.12%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.01%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), Calithera Biosciences, Inc. (0.40%), Clever Leaves Holdings Inc. (0.48%), OncoSec Medical Incorporated (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Genocea Biosciences stock?

Short selling GNCAQ is an investing strategy that aims to generate trading profit from Genocea Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genocea Biosciences?

A short squeeze for Genocea Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNCAQ, which in turn drives the price of the stock up even further.

How often is Genocea Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNCAQ, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:GNCAQ) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners